Archives for July 12, 2006

← 2006

Pycnogenol outperforms drug in CVI trial

By  staff reporter

A new study has shown Pycnogenol to be more effective than a conventional drug in reducing the symptoms of chronic venous insufficiency (CVI), adding to 35 years of research into the benefits of the antioxidant derived from French pine bark.

Berry extracts could offer stellar brain protection

By  Stephen Daniells

Extracts from blueberries and strawberries could protect against the oxidative stress behind aging, and could even protect astronauts from dangerous galactic radiation, suggests a new study partly supported by NASA.

4EVERON is not on, says FDA

By  Clarisse Douaud

The FDA has exerted post-market regulatory muscle by testing the contents of several sexual health supplements sold via the Internet in a first-of-its-kind survey and subsequently issued a warning, in which it calls them illegal drugs.

Healthy snacks grow at expense of less healthy options, report

By  Lorraine Heller

The general trend towards healthier eating has resulted in American consumers turning away from carefree snacks, and opting instead for healthier products, according to Snack Food Trends in the US, a new report by Packaged Facts.

ReGen signs first deal for Colostrinin

By  Jess Halliday

ReGen Therapeutics is poised for the first launch of its Colostrinin neutraceutical for early stage cognitive decline, with the signing of a licensing agreement with Metagenics in North America.

Mr Cookie takes Meg-3 into school meals

By  staff reporter

Ocean Nutrition Canada has brought omega-3 to school lunches in Ontario, teaming up with school supplier Good Foods Enterprises with a cookie containing its proprietary fish oil ingredient MEG-3.